CDT — CDT Equity Share News
0.000.00%
Last trade - 00:00Brief: Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders
Brief: Conduit Pharmaceuticals Announces Appointment Of Simon Fry To Board Of Directors
Brief: Conduit Pharmaceuticals Announces New Addition To Its Autoimmune Pipeline
Brief: Conduit Pharmaceuticals announces debt restructuring
Brief: Astrazeneca PLC Reports 9.9% Passive Stake In Conduit Pharmaceuticals Inc As Of August 7 - SEC Filing
Brief: Conduit Pharmaceuticals Forms Review Committee To Investigate Trading Patterns Of Certain Stockholders
Brief: Conduit Pharmaceuticals Selects Initial Indications For Lead Clinical Candidate Targeting Autoimmune Disorders
Brief: Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
Brief: Conduit Pharmaceuticals-On April 11,Determined Financial Statements For 3 Months Ended March,June, Sept 2023 Should No Longer Be Relied Upon
Brief: Vela Technologies To Sell Economic Interest In Commercialisation Of COVID Application Of AZD1656 For £4 Mln
Brief: Murphy Canyon Acquisition Corp- Enters Into A Definitive Business Combination Agreement With Conduit Pharmaceuticals Limited